Find a Biotech job in Boston

Genzyme plant gets agency approval

Genzyme Corp. said it has received correspondence from the European Medicines Agency, the main drug regulatory agency for Europe, finding the Cambridge biotechnology company’s Allston plant “in general compliance with the principles and guidelines of good manufacturing practice.’’ (Boston Globe, 11/2/09)

Lexington’s Pulmatrix raises $30m

Pulmatrix has raised $30 million to help the Lexington biotechnology company develop treatments for respiratory illnesses, according to a release from the company. (Boston Globe, 11/2/09)

Vertex pitches hepatitis drug to key doctors

With thousands of gastroenterologists and hepatologists converging on Boston for this week’s annual meeting of the American Association for the Study of Liver Diseases - a forum known as “the liver meeting’’ - a Cambridge biotechnology company is preparing a show of force to highlight its drug to treat the hepatitis C virus. (Boston Globe, 11/1/09)

15 states sue Amgen alleging kickback scheme

Biotechnology behemoth Amgen Inc. is being sued by 15 states alleging the company gave kickbacks to medical providers to help boost sales of the anemia drug Aranesp. (AP, 10/30/09)

Stryker Biotech faces indictment

A federal grand jury indicted a Hopkinton medical device maker and several key employees yesterday on charges that they illegally marketed a surgical device and covered up the misconduct. (Boston Globe, 10/28/09)